Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
Titel:
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
Auteur:
Czepielewski, M.A. Garret, Q. Vencio, S.A.C. Rassi, N. Faria, M.S. Senn, C.C.P. Bronstein, M.D. Cerqueira, M.J.A.G. Neves, A.C.L. Spinola-Castro, A.M. Cunha, M.P.R. Leite, N.R. Wassermann, G.E. Alegria, M.C. Toffoletto, O. Afiune, J. Baradelli, R. Rodrigues, D.G. Scharf, M.